Skip to main content

Inari Medical, Inc.

NARIDelisted
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001531048

Inari Medical, Inc. was delisted in 2025; its insiders filed their last Form 4 on Feb 19, 2025; 258 institutions reported holding it in 13F filings for Q4 2024, worth $2.94B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Inari Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Inari Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Inari Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Mead Dana G Jr.Director0Feb 19, 20250
Root Jonathan DDirector0IndirectFeb 19, 20250
Milder Donald BDirector0IndirectFeb 19, 20250
Hoffman WilliamDirector0Feb 19, 20250
Lucchese Cynthia LDirector0Feb 19, 20250
Szyman Catherine M.Director0Feb 19, 20250
Tu ThomasChief Medical Officer0Feb 19, 20250
Hykes AndrewPresident and CEO0Feb 19, 20250
Chambers RebeccaDirector0Feb 19, 20250
Warner Robert KeithDirector0Feb 19, 20250
Strange Kevin TChief Financial Officer0Feb 19, 20250
Silva KarenPrincipal Accounting Officer0Feb 19, 20250
Hill, Mitch C.Chief Financial Officer177,533Oct 2, 20240
Nielsen Kirk G.Director61,479May 30, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 8, 2025 (view filing)Jan 62 daysHoffman WilliamDirectorSSale−200.0K$60.47−$12.1M−45.6%239.0K after2 lots10b5-1
Dec 20, 2024 (view filing)Dec 20Same dayHykes AndrewPresident and CEOSSale−3.00K$55.29−$165.9K−0.7%439.3K after2 lots10b5-1
Dec 18, 2024 (view filing)Dec 162 daysHoffman WilliamDirectorSSale−60.0K$55.66−$3.34M−12.0%441.2K after8 lots10b5-1
Dec 12, 2024 (view filing)Dec 102 daysTu ThomasChief Medical OfficerSSale−4.00K$55.00−$220.0K−1.3%304.0K after10b5-1
Nov 22, 2024 (view filing)Nov 202 daysHykes AndrewPresident and CEOSSale−3.00K$50.83−$152.5K−0.7%442.3K after10b5-1
Nov 20, 2024 (view filing)Nov 182 daysHoffman WilliamDirectorSSale−60.0K$51.16−$3.07M−10.7%501.2K after5 lots10b5-1
Oct 31, 2024 (view filing)Oct 292 daysHykes AndrewPresident and CEOSSale−3.00K$50.00−$150.0K−0.7%445.3K after10b5-1
Oct 31, 2024 (view filing)Oct 292 daysHoffman WilliamDirectorSSale−40.0K$50.05−$2.00M−6.7%561.2K after2 lots10b5-1
Oct 18, 2024 (view filing)Oct 162 daysHoffman WilliamDirectorSSale−40.0K$45.02−$1.80M−6.2%601.2K after2 lots10b5-1
Sep 18, 2024 (view filing)Sep 162 daysHoffman WilliamDirectorSSale−40.0K$45.83−$1.83M−5.9%643.3K after2 lots10b5-1
Sep 13, 2024 (view filing)4:35 PM ETSep 121 dayHill, Mitch C.Chief Financial OfficerSSale−3.00K$45.13−$135.4K−1.6%179.6K after3 lots10b5-1
Aug 22, 2024 (view filing)Aug 202 daysHykes AndrewPresident and CEOSSale−3.00K$50.00−$150.0K−0.7%452.5K after10b5-1
Aug 20, 2024 (view filing)Aug 16-194 daysHoffman WilliamDirectorSSale−60.0K$49.36−$2.96M−8.1%683.3K after3 lots10b5-1
Aug 14, 2024 (view filing)5:10 PM ETAug 122 daysHill, Mitch C.Chief Financial OfficerSSale−5.00K$47.99−$240.0K−2.7%179.6K after2 lots10b5-1
Jul 24, 2024 (view filing)Jul 222 daysHykes AndrewPresident and CEOSSale−3.00K$55.23−$165.7K−0.7%455.3K after10b5-1
Jul 18, 2024 (view filing)Jul 162 daysHoffman WilliamDirectorSSale−60.0K$56.74−$3.40M−7.5%743.3K after10 lots10b5-1
Jul 18, 2024 (view filing)Jul 162 daysTu ThomasChief Medical OfficerSSale−3.48K$55.16−$192.0K−1.1%309.8K after10b5-1
Jul 16, 2024 (view filing)4:40 PM ETJul 124 daysHill, Mitch C.Chief Financial OfficerSSale−5.00K$53.95−$269.8K−2.7%179.2K after2 lots10b5-1
Jul 16, 2024 (view filing)Jul 151 dayTu ThomasChief Medical OfficerSSale−16.5K$55.09−$910.1K−5.0%313.3K after3 lots10b5-1
Jul 3, 2024 (view filing)Jul 12 daysHoffman WilliamDirectorSSale−20.0K$50.15−$1.00M−2.4%805.4K after10b5-1
Jul 3, 2024 (view filing)Jul 12 daysHykes AndrewPresident and CEOSSale−3.00K$50.08−$150.2K−0.6%462.5K after10b5-1
Jun 24, 2024 (view filing)Jun 213 daysChambers RebeccaDirectorSSale−260$45.99−$12.0K−2.6%9.68K after10b5-1
Jun 20, 2024 (view filing)Jun 173 daysHoffman WilliamDirectorSSale−40.0K$43.54−$1.74M−4.6%825.4K after4 lots10b5-1
Jun 14, 2024 (view filing)4:52 PM ETJun 122 daysHill, Mitch C.Chief Financial OfficerSSale−5.00K$47.60−$238.0K−2.7%181.3K after2 lots10b5-1
May 31, 2024 (view filing)Nov 7-8, 2023206 daysMilder Donald BDirectorPPurchase+56.1K$53.44+$3.00M+1.9%3.03M afterAmended3 lots
May 30, 2024 (view filing)May 282 daysHykes AndrewPresident and CEOSSale−3.00K$50.00−$150.0K−0.6%465.5K after10b5-1
May 30, 2024 (view filing)May 282 daysHoffman WilliamDirectorSSale−60.0K$50.13−$3.01M−6.5%865.4K after10b5-1
May 21, 2024 (view filing)May 201 dayChambers RebeccaDirectorSSale−964$45.39−$43.8K−8.8%9.94K after10b5-1
May 17, 2024 (view filing)May 161 dayHoffman WilliamDirectorSSale−40.0K$46.60−$1.86M−4.1%925.4K after2 lots10b5-1
May 15, 2024 (view filing)4:39 PM ETMay 132 daysHill, Mitch C.Chief Financial OfficerSSale−6.00K$45.97−$275.8K−3.2%181.3K after3 lots10b5-1
May 3, 2024 (view filing)May 12 daysHoffman WilliamDirectorSSale−38.5K$42.00−$1.62M−3.8%965.4K after3 lots10b5-1
Apr 18, 2024 (view filing)Apr 162 daysHoffman WilliamDirectorSSale−1.45K$40.00−$58.0K−0.1%999.8K after10b5-1
Apr 16, 2024 (view filing)4:32 PM ETApr 124 daysHill, Mitch C.Chief Financial OfficerSSale−6.00K$40.96−$245.8K−3.2%181.3K after10b5-1
Mar 20, 2024 (view filing)Mar 182 daysHoffman WilliamDirectorSSale−40.0K$41.13−$1.65M−3.8%1.00M after2 lots10b5-1
Mar 14, 2024 (view filing)4:31 PM ETMar 122 daysHill, Mitch C.Chief Financial OfficerSSale−6.00K$41.91−$251.5K−3.2%183.4K after2 lots10b5-1
Dec 19, 2023 (view filing)Dec 154 daysHoffman WilliamDirectorSSale−25.0K$65.08−$1.63M−2.3%1.05M after4 lots10b5-1
Dec 14, 2023 (view filing)4:35 PM ETDec 122 daysHill, Mitch C.Chief Financial OfficerSSale−6.50K$62.75−$407.9K−3.7%170.2K after2 lots10b5-1
Nov 17, 2023 (view filing)Nov 161 dayTu ThomasChief Medical OfficerSSale−25.5K$59.82−$1.52M−7.3%320.9K after2 lots
Nov 17, 2023 (view filing)Nov 161 dayHykes AndrewPresident and CEOSSale−37.4K$59.82−$2.24M−7.9%434.8K after2 lots
Nov 17, 2023 (view filing)Nov 152 daysHoffman WilliamDirectorSSale−25.0K$61.24−$1.53M−2.5%967.0K after6 lots10b5-1
Nov 15, 2023 (view filing)4:32 PM ETNov 132 daysHill, Mitch C.Chief Financial OfficerSSale−6.50K$56.06−$364.4K−3.7%170.2K after3 lots10b5-1
Oct 18, 2023 (view filing)Oct 162 daysHoffman WilliamDirectorSSale−25.0K$57.28−$1.43M−2.5%992.0K after8 lots10b5-1
Oct 16, 2023 (view filing)4:32 PM ETOct 124 daysHill, Mitch C.Chief Financial OfficerSSale−6.50K$55.74−$362.3K−3.7%170.2K after4 lots10b5-1
Sep 19, 2023 (view filing)Sep 154 daysHoffman WilliamDirectorSSale−25.0K$66.74−$1.67M−2.4%1.02M after5 lots10b5-1
Sep 14, 2023 (view filing)4:41 PM ETSep 122 daysHill, Mitch C.Chief Financial OfficerSSale−6.50K$67.85−$441.0K−3.6%171.8K after3 lots10b5-1
Aug 18, 2023 (view filing)Aug 162 daysHykes AndrewPresident and CEOSSale−36.7K$66.11−$2.42M−7.2%475.1K after4 lots
Aug 18, 2023 (view filing)Aug 162 daysTu ThomasChief Medical OfficerSSale−24.9K$66.11−$1.65M−6.7%348.0K after4 lots
Aug 17, 2023 (view filing)Aug 152 daysHoffman WilliamDirectorSSale−25.0K$69.02−$1.73M−2.3%1.05M after6 lots10b5-1
Aug 16, 2023 (view filing)4:46 PM ETAug 142 daysHill, Mitch C.Chief Financial OfficerSSale−6.50K$70.47−$458.1K−3.6%171.8K after5 lots10b5-1
Jul 19, 2023 (view filing)Jul 172 daysHoffman WilliamDirectorSSale−25.0K$57.08−$1.43M−2.3%1.07M after4 lots10b5-1